Matias interviews Rob Malenka.
In this episode, we discuss:
- Why progress in psychiatry is slow because the brain is the most complex organ and many disorders are highly heterogeneous
- The bottlenecks including weak replicability in research, academic politics, perverse incentives, and pharma’s avoidance of neuropsychiatry
- How breakthroughs require early detection, rigorous science, and bridging academia with biotech through venture philanthropy
- How success depends on mission-driven, ethical people who align science, capital, and patient impact.
- The opportunities in neuromodulation, data-driven precision medicine, and combination therapies.
Credits:
Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky
Produced by Caitlin Ner & Nico V. Rey
Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank
Business Trip